April 01, 2026 10:59 pm (IST)
Aurobindo Pharma receives USFDA approval for pain reliever tablets
Hyderabad, May 17 (IBNS) Aurobindo Pharma Limited, manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, announced on Tuesday that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg, and 8 mg.
Hydromorphone Hydrochloride Tablets is used to relieve moderate to severe pain in patients where the use of an opioid is appropriate, the company release said.
The company said that the approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Dilaudid (hydromorphone hydrochloride) Tablets, 2 mg, 4 mg, and 8 mg of Purdue Pharma L.P.
Quoting IMS, the company said that the approved product has an estimated market size of US$ 50 million for the twelve months ending March 2016.
The company also said this is the 12th ANDA to be approved out of Aurolife formulation facility in New Jersey, US for manufacturing non-antibiotic products and controlled substances, .
Aurobindo now has a total of 263 ANDA approvals (225 Final approvals, including 12 from Aurolife Pharma LLC and 38 tentative approvals) from USFDA.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Fuel prices rise: Premium petrol, diesel hiked amid oil price surge
Wed, Apr 01 2026
Defence PSU boom! Garden Reach Shipbuilders & Engineers stock rockets 20%—what’s driving the surge?
Wed, Apr 01 2026
Dalal Street on fire: Sensex soars, Nifty rockets—here’s why!
Wed, Apr 01 2026
Layoff alert: Oracle cuts 30,000 jobs globally, 12,000 hit in India
Wed, Apr 01 2026
PwC India announces leadership transition in Deals Business
Tue, Mar 31 2026
DBS Bank India launches relationship-led banking for 'India’s globally mobile, emerging affluent'
Tue, Mar 31 2026
Major expansion ahead: Govt clears 29 proposals under ECMS
Tue, Mar 31 2026
